The influence of Medicare Part D on the list pricing of brand drugs

OBJECTIVE: To compare the Medicare Part D market share of brand drugs with their net‐to‐list price ratio. DATA SOURCES AND STUDY SETTING: SSR Health Brand Net Price Tool and Medical Expenditure Panel Survey, 2007–2019. STUDY DESIGN: For each drug, we calculated the ratio of net to list price and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ippolito, Benedic N., Levy, Joseph F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2023
Materias:
Medication Policy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315368/
https://www.ncbi.nlm.nih.gov/pubmed/36737865
http://dx.doi.org/10.1111/1475-6773.14139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315368/
https://www.ncbi.nlm.nih.gov/pubmed/36737865
http://dx.doi.org/10.1111/1475-6773.14139

Ejemplares similares